BEIJING, Feb. 29,
2024 /PRNewswire/ -- iHuman Inc. (NYSE: IH)
("iHuman" or the "Company"), a leading provider of tech-powered,
intellectual development products in China, today announced its unaudited financial
results for the fourth quarter and fiscal year ended December 31, 2023.
Fourth Quarter 2023 Highlights
- Revenues were RMB250.4 million
(US$35.3 million), compared with
RMB260.7 million in the same period
last year.
- Gross profit was RMB178.2 million
(US$25.1 million), compared with
RMB181.0 million in the same period
last year.
- Operating income was RMB21.9
million (US$3.1 million),
compared with RMB39.1 million in the
same period last year.
- Net income was RMB33.3 million
(US$4.7 million), compared with
RMB35.4 million in the same period
last year.
- Average total MAUs[1] reached a record-high of 25.38
million, a year-over-year increase of 14.2%.
Fiscal Year 2023 Highlights
- Revenues were RMB1,018.1 million
(US$143.4 million), compared with
RMB985.5 million in fiscal year
2022.
- Gross profit was RMB721.3 million
(US$101.6 million), compared with
RMB691.2 million in fiscal year
2022.
- Operating income was RMB159.9
million (US$22.5 million),
compared with RMB111.6 million in
fiscal year 2022.
- Net income was RMB180.9 million
(US$25.5 million), compared with
RMB109.8 million in fiscal year
2022.
- Average total MAUs were 23.04 million, a year-over-year
increase of 16.0%.
[1] "Average total
MAUs" refers to the monthly average of the sum of the MAUs of each
of the Company's apps during a specific period, which is counted
based on the number of unique mobile devices through which such app
is accessed at least once in a given month, and duplicate access to
different apps is not eliminated from the total MAUs
calculation.
[2] "Paying users" refers to users who paid subscription fees for
premium content on any of the Company's apps during a specific
period; a user who makes payments across different apps using the
same registered account is counted as one paying user, and a user
who makes payments for the same app multiple times in the same
period is counted as one paying user.
|
Dr. Peng Dai, Director and Chief Executive Officer of
iHuman, commented, "As we look back on 2023, I am truly inspired by
the accomplishments that we have achieved, especially considering
the decline in China's newborn
population over the past few years. In response to the challenges
posed by the declining birth rate, we have been actively expanding
our presence in the international markets, diversifying our product
portfolio, and developing products that cover a broader age
demographic. These strategic efforts have helped us achieve
remarkable progress. For instance, our
globally-oriented app, Aha World, delivered impressive
performance in 2023. By the end of the year, its YouTube and TikTok
accounts collectively attracted over 200 million views. It also
earned YouTube's Silver Creator Award and rose to rank among the
top three most popular children's apps on the U.S. Apple app store
in the fourth quarter. Meanwhile, our flagship product,
iHuman Chinese, has consistently held the No.1 spot in the
top-grossing category for children's apps on the Apple app store in
China for iPad users for nearly
4.5 years, according to Appfigures, a reputable American data
analytics company. This past year has been marked by revenue growth
and sustained profitability, and we once again set a new record for
average total MAUs in the fourth quarter
which further solidified our position as an industry
leader."
"We are also thrilled to
announce the acquisition of intellectual property assets related to
"Cosmicrew" from Kunpeng, an animation production studio
within the Perfect World Group. This strategic acquisition is
expected to generate significant synergies with our business.
Firstly, "Cosmicrew" is a popular cartoon adventure
series that has established a strong presence in the
children's entertainment sector. The light-hearted and delightful
nature of this cartoon IP seamlessly compliments our overall
product style and aesthetic. With the IP already integrated into
some of our products before the acquisition, we now
have greater autonomy over our creative content. In addition,
we now can expand our product range further by developing
additional IP offerings and derivatives, including animations,
toys, and more. At the market level, "Cosmicrew" is a
popular cartoon with a large audience base, and this acquisition
will enable us to further extend our market reach and engage
with a broader audience."
"As we continue to progress on our strategic
initiatives, we remain fully dedicated to strengthening our core
competencies through ongoing product enhancement. We have been
enriching the content and functionality of our app products to
elevate the digital experience of our users and have made
further strides in integrating our online and offline offerings to
create a more immersive and holistic journey for users. For
example, we rolled out both multi-leveled physical books and a
specially developed smart reading pen that complement our
leveled English reading app, iHuman Fantastic Friends.
This combination allows kids to explore captivating original
English stories tailored to their proficiency level in physical and
digital formats, offering them a flexible and simple reading
experience while enhancing their understanding and engagement with
the content."
"In 2023, we further strengthened our comprehensive product
suite, significantly expanded our international presence, and
earned increased market recognition with several prestigious
industry accolades. We achieved all these milestones
despite a highly volatile and challenging macroeconomic
climate, which I believe is a testament to the caliber of our
products, the effectiveness of our
strategies, and the resilience of our team in
overcoming diverse economic challenges. As we enter 2024, I am
filled with anticipation for the continued success that lies
ahead."
Ms. Vivien Weiwei Wang, Director
and Chief Financial Officer of iHuman, added, "Our fourth quarter
results ended 2023 on a positive note despite a turbulent global
economic environment. While our fourth quarter results saw a
marginal decrease year-over-year, it reflected a normalization from
the exceptional fourth quarter performance last year, which was
caused by a heightened demand driven by more indoor activities
during the pandemic. From a full year perspective in 2023, despite
the fact that everybody shifted back to regular routines and spent
less time at home after the pandemic, we still achieved
satisfactory growth as both revenues and MAUs increased compared to
fiscal year 2022. We are also proud to announce our eighth
consecutive quarter of profitability, with annual net income
reaching RMB180.9 million. This
achievement marks our second straight year of profitability since
our IPO in 2020 and demonstrates that we have successfully charted
a path of healthy and sustainable growth. The momentum we have
sustained in our business operations has further solidified our
financial position, which not only bolsters our capacity for
ongoing growth and innovation, but also enables us to enhance
returns to our shareholders through issuing a special cash dividend
of US$0.02 per ordinary share, or
US$0.10 per ADS. The approval of the
special dividend by our board of directors reflects our confidence
in our long-term growth potential and strong balance sheet. Moving
forward, we will continue to execute on our strategic priorities
and maintain a growth-oriented approach to create even greater
value for our users and shareholders."
Fourth Quarter 2023 Unaudited Financial Results
Revenues
Revenues were RMB250.4 million
(US$35.3 million), compared with
RMB260.7 million in the same period
last year.
Average total MAUs for the quarter were 25.38 million, an
increase of 14.2% year-over-year from 22.22 million in the same
period last year. The number of paying users[2] was 1.45
million.
Cost of Revenues
Cost of revenues was RMB72.2
million (US$10.2 million), a
decrease of 9.4% from RMB79.7 million
in the same period last year, primarily due to decreased channel
costs.
Gross Profit and Gross Margin
Gross profit was RMB178.2 million
(US$25.1 million), compared with
RMB181.0 million in the same period
last year. Gross margin was 71.2%, compared with 69.4% in the same
period last year.
Operating Expenses
Total operating expenses were RMB156.4
million (US$22.0 million), an
increase of 10.2% from RMB141.9
million in the same period last year.
Research and development expenses were RMB66.3 million (US$9.3
million), compared with RMB66.8 million in the same
period last year.
Sales and marketing expenses were RMB64.5
million (US$9.1 million), an
increase of 40.8% from RMB45.8
million in the same period last year, primarily due to
increased strategic spending on promotional activities and brand
enhancement.
General and administrative expenses were RMB25.5 million (US$3.6 million), a decrease of 12.7%
from RMB29.3 million in the same period last year, primarily
due to payroll related cost-savings and other decreased expenses as
a result of the continued optimization of our operational
efficiency.
Operating Income
Operating income was RMB21.9
million (US$3.1 million),
compared with RMB39.1 million in the
same period last year.
Net Income
Net income was RMB33.3 million
(US$4.7 million), compared with
RMB35.4 million in the same period
last year.
Basic and diluted net income per ADS were RMB0.63 (US$0.09)
and RMB0.61 (US$0.09), respectively, compared with
RMB0.67 and RMB0.66 in the same period last year. Each ADS
represents five Class A ordinary shares of the Company.
Deferred Revenue and Customer
Advances
Deferred revenue and customer advances were RMB318.6 million (US$44.9 million) as of December 31, 2023, compared with RMB379.1 million as of December 31, 2022.
Cash and Cash Equivalents
Cash and cash equivalents were RMB1,213.8 million (US$171.0 million) as of December 31, 2023, compared with RMB1,050.0 million as of December 31, 2022.
Fiscal Year 2023 Unaudited Financial Results
Revenues
Revenues were RMB1,018.1 million (US$143.4 million), an increase of 3.3% from
RMB985.5 million in fiscal year
2022.
Average total MAUs were 23.04 million, an increase of 16.0%
year-over-year from 19.86 million in fiscal year 2022. The number
of paying users for the year was 4.27 million.
Cost of Revenues
Cost of revenues was RMB296.9
million (US$41.8 million),
compared with RMB294.3 million in
fiscal year 2022.
Gross Profit and Gross Margin
Gross profit was RMB721.3 million (US$101.6 million), an increase of 4.4% from
RMB691.2 million in fiscal year 2022.
Gross margin was 70.8%, compared with 70.1% in fiscal year
2022.
Operating Expenses
Total operating expenses were RMB561.4
million (US$79.1 million), a
decrease of 3.1% from RMB579.6
million in fiscal year 2022.
Research and development expenses were RMB257.5 million (US$36.3
million), a decrease of 17.8% from RMB313.5 million in fiscal year 2022, primarily
due to cost savings in payroll-related expenses and outsourcing
expenses.
Sales and marketing expenses were RMB199.5 million (US$28.1 million), an increase of 27.1% from
RMB156.9 million in fiscal year 2022,
primarily due to increased strategic spending on promotional
activities and brand enhancement.
General and administrative expenses were RMB104.3 million (US$14.7
million), a decrease of 4.5% from RMB109.2 million in fiscal year 2022.
Operating Income
Operating income was RMB159.9
million (US$22.5 million),
compared with RMB111.6 million in
fiscal year 2022.
Net Income
Net income was RMB180.9 million
(US$25.5 million), compared with
RMB109.8 million in fiscal year
2022.
Basic and diluted net income per ADS were RMB3.43 (US$0.48)
and RMB3.30 (US$0.46), respectively, compared with
RMB2.06 and RMB2.03 in fiscal year 2022. Each ADS represents
five Class A ordinary shares of the Company.
Special Cash Dividend
To deliver return of capital to shareholders, the Company's
board of directors (the "Board") approved a special cash dividend
of US$0.02 per ordinary share, or
US$0.10 per ADS, to holders of
ordinary shares and holders of ADSs as of the close of business on
March 28, 2024 New York Time, payable
in U.S. dollars. The aggregate amount of the special dividend will
be approximately US$5.3 million. The
payment date is expected to be on or around May 8, 2024 and May 15,
2024 for holders of ordinary shares and holders of ADSs,
respectively.
Acquisition of IP Assets
The Company, through one of its consolidated affiliated
entities, entered into an asset transfer agreement (the "Asset
Transfer Agreement") with Kunpeng, an animation production studio
within the Perfect World Group (the "Transferors"). Pursuant
to the Asset Transfer Agreement, the Company will acquire
intellectual property assets related to "Cosmicrew" from
Kunpeng, including copyrights and trademarks, among others, for a
total consideration of RMB64.0 million. The consideration of the
transaction was determined with the assistance of an independent
third-party valuation firm. As the Transferors are related parties
of the Company, the transaction has been approved by the Board and
the audit committee of the Board, and is subject to customary
closing conditions.
Exchange Rate Information
The U.S. dollar (US$) amounts disclosed in this press release,
except for those transaction amounts that were actually settled in
U.S. dollars, are presented solely for the convenience of the
reader. The conversion of Renminbi (RMB) into US$ in this press
release is based on the exchange rate set forth in the H.10
statistical release of the Board of Governors of the Federal
Reserve System as of December 29,
2023, which was RMB7.0999 to
US$1.00. The percentages stated in
this press release are calculated based on the RMB amounts.
Non-GAAP Financial Measures
iHuman considers and uses non-GAAP financial measures, such as
adjusted operating income, adjusted net income and adjusted diluted
net income per ADS, as supplemental metrics in reviewing and
assessing its operating performance and formulating its business
plan. The presentation of non-GAAP financial measures is not
intended to be considered in isolation or as a substitute for the
financial information prepared and presented in accordance with
accounting principles generally accepted in the United States of America ("U.S. GAAP").
iHuman defines adjusted operating income, adjusted net income and
adjusted diluted net income per ADS as operating income, net income
and diluted net income per ADS excluding share-based compensation
expenses, respectively. Adjusted operating income, adjusted net
income and adjusted diluted net income per ADS enable iHuman's
management to assess its operating results without considering the
impact of share-based compensation expenses, which are non-cash
charges. iHuman believes that these non-GAAP financial measures
provide useful information to investors in understanding and
evaluating the Company's current operating performance and
prospects in the same manner as management does, if they so
choose.
Non-GAAP financial measures are not defined under U.S. GAAP and
are not presented in accordance with U.S. GAAP. Non-GAAP financial
measures have limitations as analytical tools, which possibly do
not reflect all items of expense that affect our operations.
Share-based compensation expenses have been and may continue to be
incurred in our business and are not reflected in the presentation
of the non-GAAP financial measures. In addition, the non-GAAP
financial measures iHuman uses may differ from the non-GAAP
measures used by other companies, including peer companies, and
therefore their comparability may be limited. The presentation of
these non-GAAP financial measures is not intended to be considered
in isolation from or as a substitute for the financial information
prepared and presented in accordance with GAAP.
Safe Harbor Statement
This announcement contains forward-looking statements. These
statements are made under the "safe harbor" provisions of the
United States Private Securities Litigation Reform Act of 1995.
These forward-looking statements can be identified by terminology
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar statements.
Statements that are not historical facts, including statements
about iHuman's beliefs and expectations, are forward-looking
statements. Among other things, the description of the management's
quotations in this announcement contains forward-looking
statements. iHuman may also make written or oral forward-looking
statements in its periodic reports to the U.S. Securities and
Exchange Commission (the "SEC"), in its annual report to
shareholders, in press releases and other written materials, and in
oral statements made by its officers, directors or employees to
third parties. Forward-looking statements involve inherent risks
and uncertainties. A number of factors could cause actual results
to differ materially from those contained in any forward-looking
statement, including but not limited to the following: iHuman's
growth strategies; its future business development, financial
condition and results of operations; its ability to continue to
attract and retain users, convert non-paying users into paying
users and increase the spending of paying users, the trends in, and
size of, the market in which iHuman operates; its expectations
regarding demand for, and market acceptance of, its products and
services; its expectations regarding its relationships with
business partners; general economic and business conditions;
regulatory environment; and assumptions underlying or related to
any of the foregoing. Further information regarding these and other
risks is included in iHuman's filings with the SEC. All information
provided in this press release is as of the date of this press
release, and iHuman does not undertake any obligation to update any
forward-looking statement, except as required under applicable
law.
About iHuman Inc.
iHuman Inc. is a leading provider of tech-powered, intellectual
development products in China that
is committed to making the child-upbringing experience easier for
parents and transforming intellectual development into a fun
journey for children. Benefiting from a deep legacy that combines
over two decades of experience in the parenthood industry, superior
original content, advanced high-tech innovation DNA and research
& development capabilities with cutting-edge technologies,
iHuman empowers parents with tools to make the child-upbringing
experience more efficient. iHuman's unique, fun and interactive
product offerings stimulate children's natural curiosity and
exploration. The Company's comprehensive suite of innovative and
high-quality products include self-directed apps, interactive
content and smart devices that cover a broad variety of areas to
develop children's abilities in speaking, critical thinking,
independent reading and creativity, and foster their natural
interest in traditional Chinese culture. Leveraging advanced
technological capabilities, including 3D engines, AI/AR
functionality, and big data analysis on children's behavior &
psychology, iHuman believes it will continue to provide superior
experience that is efficient and relieving for parents, and
effective and fun for children, in China and all over the world, through its
integrated suite of tech-powered, intellectual development
products.
For more information about iHuman, please visit
https://ir.ihuman.com/.
For investor and media enquiries, please contact:
iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86 10 5780-6606
E-mail: ir@ihuman.com
Christensen
In China
Ms. Alice
Li
Phone: +86-10-5900-1548
E-mail: alice.li@christensencomms.com
In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: linda.bergkamp@christensencomms.com
iHuman Inc.
UNAUDITED CONDENSED
CONSOLIDATED BALANCE SHEETS
(Amounts in
thousands of Renminbi ("RMB") and U.S. dollars
("US$")
except for number of
shares, ADSs, per share and per ADS
data)
|
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
|
2022
|
|
2023
|
|
2023
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
Current
assets
|
|
|
|
|
|
Cash and cash
equivalents
|
1,049,999
|
|
1,213,767
|
|
170,956
|
Accounts receivable,
net
|
79,614
|
|
60,832
|
|
8,568
|
Inventories,
net
|
19,127
|
|
16,518
|
|
2,327
|
Amounts due from
related parties
|
2,286
|
|
1,810
|
|
255
|
Prepayments and other
current assets
|
102,765
|
|
89,511
|
|
12,607
|
Total current
assets
|
1,253,791
|
|
1,382,438
|
|
194,713
|
Non-current
assets
|
|
|
|
|
|
Property and
equipment, net
|
9,205
|
|
6,169
|
|
869
|
Intangible assets,
net
|
24,872
|
|
23,245
|
|
3,274
|
Operating
lease right-of-use assets
|
12,782
|
|
3,648
|
|
514
|
Long-term
investment
|
26,333
|
|
26,333
|
|
3,709
|
Other non-current
assets
|
6,416
|
|
8,662
|
|
1,218
|
Total non-current
assets
|
79,608
|
|
68,057
|
|
9,584
|
Total
assets
|
1,333,399
|
|
1,450,495
|
|
204,297
|
|
|
|
|
|
|
LIABILITIES
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
Accounts
payable
|
24,206
|
|
22,139
|
|
3,118
|
Deferred revenue and
customer advances
|
379,063
|
|
318,587
|
|
44,872
|
Amounts due to related
parties
|
6,944
|
|
4,428
|
|
624
|
Accrued expenses and
other current liabilities
|
144,717
|
|
143,677
|
|
20,236
|
Current operating
lease liabilities
|
6,123
|
|
1,927
|
|
271
|
Total current
liabilities
|
561,053
|
|
490,758
|
|
69,121
|
Non-current
liabilities
|
|
|
|
|
|
Non-current operating
lease liabilities
|
2,894
|
|
1,933
|
|
272
|
Total non-current
liabilities
|
2,894
|
|
1,933
|
|
272
|
Total
liabilities
|
563,947
|
|
492,691
|
|
69,393
|
SHAREHOLDERS'
EQUITY
|
|
|
|
|
|
Ordinary shares (par
value of US$0.0001 per share,
700,000,000 Class A shares authorized as of
December 31, 2022 and December 31, 2023;
125,122,382 Class A shares issued and 121,722,467
outstanding as of December 31, 2022; 125,122,382
Class A shares issued and 119,704,787 outstanding as
of December 31, 2023; 200,000,000 Class B shares
authorized, 144,000,000 Class B ordinary shares
issued and outstanding as of December 31, 2022 and
December 31, 2023; 100,000,000 shares
(undesignated) authorized, nil shares
(undesignated)
issued and outstanding as of December 31, 2022 and
December 31, 2023)
|
185
|
|
185
|
|
26
|
Additional paid-in
capital
|
1,079,099
|
|
1,088,628
|
|
153,330
|
Treasury
stock
|
(7,123)
|
|
(16,665)
|
|
(2,347)
|
Statutory
reserves
|
7,967
|
|
8,164
|
|
1,150
|
Accumulated other
comprehensive income
|
10,497
|
|
17,955
|
|
2,529
|
Accumulated
deficit
|
(321,173)
|
|
(140,463)
|
|
(19,784)
|
Total shareholders'
equity
|
769,452
|
|
957,804
|
|
134,904
|
Total liabilities
and shareholders' equity
|
1,333,399
|
|
1,450,495
|
|
204,297
|
iHuman Inc.
UNAUDITED CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands of Renminbi ("RMB") and U.S.
dollars ("US$")
except for number of
shares, ADSs, per share and per ADS data)
|
|
|
|
|
|
For the three months
ended
|
|
For the year
ended
|
|
December
31,
|
|
September
30,
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
|
2022
|
|
2023
|
|
2023
|
|
2023
|
|
2022
|
|
2023
|
|
2023
|
|
RMB
|
|
RMB
|
|
RMB
|
|
US$
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
260,704
|
|
261,496
|
|
250,447
|
|
35,275
|
|
985,517
|
|
1,018,139
|
|
143,402
|
Cost of
revenues
|
(79,707)
|
|
(74,871)
|
|
(72,201)
|
|
(10,169)
|
|
(294,343)
|
|
(296,868)
|
|
(41,813)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
profit
|
180,997
|
|
186,625
|
|
178,246
|
|
25,106
|
|
691,174
|
|
721,271
|
|
101,589
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development expenses
|
(66,796)
|
|
(66,168)
|
|
(66,293)
|
|
(9,337)
|
|
(313,481)
|
|
(257,546)
|
|
(36,275)
|
Sales and marketing
expenses
|
(45,811)
|
|
(53,994)
|
|
(64,511)
|
|
(9,086)
|
|
(156,916)
|
|
(199,504)
|
|
(28,100)
|
General and
administrative expenses
|
(29,253)
|
|
(26,070)
|
|
(25,547)
|
|
(3,598)
|
|
(109,195)
|
|
(104,334)
|
|
(14,695)
|
Total operating
expenses
|
(141,860)
|
|
(146,232)
|
|
(156,351)
|
|
(22,021)
|
|
(579,592)
|
|
(561,384)
|
|
(79,070)
|
Operating
income
|
39,137
|
|
40,393
|
|
21,895
|
|
3,085
|
|
111,582
|
|
159,887
|
|
22,519
|
Other income,
net
|
5,315
|
|
19,507
|
|
8,965
|
|
1,263
|
|
21,190
|
|
42,686
|
|
6,012
|
Income before income
taxes
|
44,452
|
|
59,900
|
|
30,860
|
|
4,348
|
|
132,772
|
|
202,573
|
|
28,531
|
Income tax (expenses) /
benefits
|
(9,019)
|
|
(7,984)
|
|
2,411
|
|
340
|
|
(22,953)
|
|
(21,666)
|
|
(3,052)
|
Net
income
|
35,433
|
|
51,916
|
|
33,271
|
|
4,688
|
|
109,819
|
|
180,907
|
|
25,479
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per
ADS:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
Basic
|
0.67
|
|
0.98
|
|
0.63
|
|
0.09
|
|
2.06
|
|
3.43
|
|
0.48
|
-
Diluted
|
0.66
|
|
0.95
|
|
0.61
|
|
0.09
|
|
2.03
|
|
3.30
|
|
0.46
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average
number of ADSs:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
Basic
|
53,205,925
|
|
52,747,426
|
|
52,740,067
|
|
52,740,067
|
|
53,307,044
|
|
52,810,587
|
|
52,810,587
|
-
Diluted
|
54,033,560
|
|
54,772,536
|
|
54,753,503
|
|
54,753,503
|
|
54,040,908
|
|
54,753,025
|
|
54,753,025
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total share-based
compensation expenses included in:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of
revenues
|
168
|
|
67
|
|
64
|
|
9
|
|
348
|
|
299
|
|
42
|
Research and
development expenses
|
2,564
|
|
1,160
|
|
1,115
|
|
157
|
|
6,377
|
|
4,055
|
|
571
|
Sales and marketing
expenses
|
559
|
|
147
|
|
122
|
|
17
|
|
1,599
|
|
707
|
|
100
|
General and
administrative expenses
|
1,757
|
|
1,105
|
|
817
|
|
115
|
|
4,720
|
|
4,374
|
|
616
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
iHuman Inc.
UNAUDITED
RECONCILIATION OF GAAP AND NON-GAAP RESULTS
(Amounts in
thousands of Renminbi ("RMB") and U.S. dollars
("US$")
except for number
of shares, ADSs, per share and per ADS data)
|
|
|
|
|
|
For the three months
ended
|
|
For the year
ended
|
|
December
31,
|
|
September
30,
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
|
December
31,
|
|
2022
|
|
2023
|
|
2023
|
|
2023
|
|
2022
|
|
2023
|
|
2023
|
|
RMB
|
|
RMB
|
|
RMB
|
|
US$
|
|
RMB
|
|
RMB
|
|
US$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income
|
39,137
|
|
40,393
|
|
21,895
|
|
3,085
|
|
111,582
|
|
159,887
|
|
22,519
|
Share-based
compensation expenses
|
5,048
|
|
2,479
|
|
2,118
|
|
298
|
|
13,044
|
|
9,435
|
|
1,329
|
Adjusted operating
income
|
44,185
|
|
42,872
|
|
24,013
|
|
3,383
|
|
124,626
|
|
169,322
|
|
23,848
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income
|
35,433
|
|
51,916
|
|
33,271
|
|
4,688
|
|
109,819
|
|
180,907
|
|
25,479
|
Share-based
compensation expenses
|
5,048
|
|
2,479
|
|
2,118
|
|
298
|
|
13,044
|
|
9,435
|
|
1,329
|
Adjusted net
income
|
40,481
|
|
54,395
|
|
35,389
|
|
4,986
|
|
122,863
|
|
190,342
|
|
26,808
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted net income per
ADS
|
0.66
|
|
0.95
|
|
0.61
|
|
0.09
|
|
2.03
|
|
3.30
|
|
0.46
|
Impact of non-GAAP
adjustments
|
0.09
|
|
0.04
|
|
0.04
|
|
0.00
|
|
0.24
|
|
0.18
|
|
0.03
|
Adjusted diluted net
income per ADS
|
0.75
|
|
0.99
|
|
0.65
|
|
0.09
|
|
2.27
|
|
3.48
|
|
0.49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number
of ADSs – diluted
|
54,033,560
|
|
54,772,536
|
|
54,753,503
|
|
54,753,503
|
|
54,040,908
|
|
54,753,025
|
|
54,753,025
|
Weighted average
number of ADSs – adjusted
|
54,033,560
|
|
54,772,536
|
|
54,753,503
|
|
54,753,503
|
|
54,040,908
|
|
54,753,025
|
|
54,753,025
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-fourth-quarter-and-fiscal-year-2023-unaudited-financial-results-302075140.html
SOURCE iHuman Inc.